Emphasis on Drug Class (Buprenorphine, Methadone, and Naltrexone); Route of Administration (Oral and Parenteral); Distribution Channel (Hospital Pharmacies, Retail Pharmacies & Stores, and Online Pharmacies); and Region/Country
Opioid Use Disorder (OUD) Treatment Market Size & ForecastThe opioid use disorder (OUD) treatment market was valued at approximately ~USD 3.2 billion in 2023 and is expected to grow at a strong CAGR of around 8.1% during the forecast period (2024-2032) owing to the increase in drug awareness campaigns & associated preventive programs.
The market for OUD treatment is growing very fast due to the opioid crisis and the variety of therapeutic approaches is contributing to this market. This market includes medication-assisted treatments such as methadone, buprenorphine, and naltrexone, which are popular because of their ability to effectively help with withdrawal symptoms and relapse rates. In conjunction with MAT, there are behavioral therapies and psychosocial interventions that enhance the treatment. Market growth can also be attributed to increased population awareness, government involvement, and funding towards the prevention and combating of substance dependency.
In July 2024, the Food and Drug Administration launched a new educational program called “Prescribe with Confidence” that aims to help providers identify and treat opioid use disorder (OUD).
In April 2024, the University of Texas Health Science Center at San Antonio (UT Health San Antonio) is establishing the Be Well Institute on Substance Use and Related Disorders, a pioneering initiative dedicated to advancing research, education, and evidence-based treatments.
This section discusses the key market trends that are influencing the various segments of the opioid use disorder (OUD) treatment market, as identified by our team of research experts.
The parenteral segment in the opioid use disorder (OUD) treatment market has experienced a significant uplift due to the efficacy and the longer span of injectable products. Other drugs like Extended-release Naltrexone (Vivitrol) Series carry a lot of following due to long-lasting opioid Receptor blockers which assist in cravings and help in avoiding relapse period. This segment’s growth is also backed by enhancements in formulation technology as well as the rising endorsement by clinicians related to their superb adherence and effectiveness in addressing OUD. Moreover, the trend to employ multidimensional treatment regimens and patient adherence has also contributed to the strengthening of parenteral treatments for the total management of OUD, further boosting its role in the management of OUD.
North America’s market for OUD treatment has been growing steadily over the years due to increased awareness of the OUD, the upsurge of opioid abuse, and the general development of the healthcare sector. Increasing rates of opioid addiction in countries within this region have led to a notable rise in both medication-assisted therapy and behavioral therapies. There is increased emphasis on governments’ action and international partnerships as they seek to expand the availability of proper treatment regimens, including buprenorphine and naltrexone, and modalities of care. Moreover, enhanced technology in telemedicine and online pharmacies has enabled patients’ easy access to medication thus contributing to the growth of the market. This expansion is an indication of efforts to address the situation with opioids and enhance patient care across differing North American countries.
In April 2024, Ophelia, a physician practice that treats opioid addiction, was designated as an Opioid Use Disorder (OUD) Center of Excellence (COE) by Pennsylvania’s Department of Human Services, becoming the first virtual-first and statewide COE. Ophelia uses a virtual-first care model to improve access and retention in evidence-based OUD treatment by lowering barriers to care for rural, underserved, and historically stigmatized patient populations. Since entering Pennsylvania in 2020, it has served thousands of Medicaid beneficiaries in the state.
In October 2021, U.S.-based Groups Recover Together (Groups), the national leader in value-based care for opioid addiction treatment, announced the launch of a proprietary digital platform for their members. The platform, an app-centric experience that offers the full suite of Group’s services and is designed to simplify the member experience, boasts features around self-scheduling, outreach, contextualized content, treatment planning, group therapy, payment, forms, and more.
The opioid use disorder (OUD) treatment market is competitive, with several global and international market players. The key players are adopting different growth strategies to enhance their market presence, such as partnerships, agreements, collaborations, geographical expansions, and mergers and acquisitions. Some of the major players operating in the market are MediciNova, Inc.; Aphios Corporation; Braeburn Inc.; Alkermes; Indivior PLC; Zynerba Pharmaceuticals, Inc.; Mylan N.V.; Janssen Global Services, LLC; Sandoz AG; Cumberland Pharmaceuticals Inc.
In July 2024, virtual OUD provider Bicycle Health launched a program for teens ages 16 and 17 who live in Maine, offering them virtual treatment and access to evidence-based medications for opioid use disorder (MOUDs).
In April 2022, Pear Therapeutics launched a program to offer digital therapeutic users access to a telehealth provider. Boston-based Pear’s program offers patients seeking treatment for substance use disorder (SUD) or opioid use disorder (OUD) access to a telehealth provider through its “find a provider tool,” as well as in-person care options.
The global opioid use disorder (OUD) treatment market can further be customized as per the requirement or any other market segment. Besides this, UMI understands that you may have your own business needs, hence feel free to connect with us to get a report that completely suits your requirements.
1. Market Introduction
2. Research Methodology Or Assumption
3. Executive Summary
4. Market Dynamics
5. Pricing Analysis
6. Global Opioid Use Disorder (oud) Treatment Market Revenue (usd Bn), 2022-2032f
7. Market Insights By Drug Class
8. Market Insights By Route Of Administration
9. Market Insights By Distribution Channel
10. Market Insights By Region
11. Treatment Landscape Of Opioid Use Disorder
12. Value Chain Analysis
13. Competitive Landscape
14. Company Profiles
15. Acronyms & Assumption
16. Annexure
Analyzing the historical market, estimating the current market, and forecasting the future market of the global opioid use disorder (OUD) treatment market were the three major steps undertaken to create and analyze the adoption of opioid use disorder (OUD) treatments in major regions globally. Exhaustive secondary research was conducted to collect the historical market numbers and estimate the current market size. Secondly, to validate these insights, numerous findings and assumptions were taken into consideration. Moreover, exhaustive primary interviews were also conducted, with industry experts across the value chain of the global opioid use disorder (OUD) treatment market. Post assumption and validation of market numbers through primary interviews, we employed a top-down/bottom-up approach to forecasting the complete market size. Thereafter, market breakdown and data triangulation methods were adopted to estimate and analyze the market size of segments and sub-segments of the industry pertains to. Detailed methodology is explained below:
Analysis of Historical Market Size
Step 1: In-Depth Study of Secondary Sources:
A detailed secondary study was conducted to obtain the historical market size of the opioid use disorder (OUD) treatment market through company internal sources such as annual reports & financial statements, performance presentations, press releases, etc., and external sources including journals, news & articles, government publications, competitor publications, sector reports, third-party database, and other credible publications.
Step 2: Market Segmentation:
After obtaining the historical market size of the opioid use disorder (OUD) treatment market, we conducted a detailed secondary analysis to gather historical market insights and share for different segments & sub-segments for major regions. Major segments are included in the report, such as drug class, route of administration, distribution channel, and regions. Further country-level analyses were conducted to evaluate the overall adoption of testing models in that region.
Step 3: Factor Analysis:
After acquiring the historical market size of different segments and sub-segments, we conducted a detailed factor analysis to estimate the current market size of the opioid use disorder (OUD) treatment market. Further, we conducted factor analysis using dependent and independent variables such as drug class, route of administration, distribution channel, and regions of the opioid use disorder (OUD) treatment market. A thorough analysis was conducted for demand and supply-side scenarios considering top partnerships, mergers and acquisitions, business expansion, and product launches in the opioid use disorder (OUD) treatment market sector across the globe.
Current Market Size Estimate & Forecast
Current Market Sizing: Based on actionable insights from the above 3 steps, we arrived at the current market size, key players in the global opioid use disorder (OUD) treatment market, and market shares of the segments. All the required percentage shares split and market breakdowns were determined using the above-mentioned secondary approach and were verified through primary interviews.
Estimation & Forecasting: For market estimation and forecast, weights were assigned to different factors including drivers & trends, restraints, and opportunities available for the stakeholders. After analyzing these factors, relevant forecasting techniques i.e., the top-down/bottom-up approach were applied to arrive at the market forecast for 2032 for different segments and sub-segments across the major markets globally. The research methodology adopted to estimate the market size encompasses:
The industry’s market size, in terms of revenue (USD) and the adoption rate of the opioid use disorder (OUD) treatment market across the major markets domestically.
All percentage shares, splits, and breakdowns of market segments and sub-segments.
Key players in the global opioid use disorder (OUD) treatment market in terms of products offered. Also, the growth strategies adopted by these players to compete in the fast-growing market.
Market Size and Share Validation
Primary Research: In-depth interviews were conducted with the Key Opinion Leaders (KOLs) including Top Level Executives (CXO/VPs, Sales Head, Marketing Head, Operational Head, Regional Head, Country Head, etc.) across major regions. Primary research findings were then summarized, and statistical analysis was performed to prove the stated hypothesis. Inputs from primary research were conso0lidated with secondary findings, hence turning information into actionable insights.
Split of Primary Participants in Different Regions
Market Engineering
The data triangulation technique was employed to complete the overall market estimation and to arrive at precise statistical numbers for each segment and sub-segment of the global opioid use disorder (OUD) treatment market. Data was split into several segments and sub-segments after studying various parameters and trends in the areas of the drug class, route of administration, distribution channel, and regions in the global opioid use disorder (OUD) treatment market.
The main objective of the Global Opioid Use Disorder (OUD) Treatment Market Study
The current & future market trends of the global opioid use disorder (OUD) treatment market were pinpointed in the study. Investors can gain strategic insights to base their discretion for investments on the qualitative and quantitative analysis performed in the study. Current and future market trends determined the overall attractiveness of the market at a regional level, providing a platform for the industrial participant to exploit the untapped market to benefit from a first-mover advantage. Other quantitative goals of the studies include:
Q1: What is the opioid use disorder (OUD) treatment market's current market size and growth potential?
Q2: What are the driving factors for the growth of the opioid use disorder (OUD) treatment market?
Q3: Which segment has the largest share of the opioid use disorder (OUD) treatment market by drug class?
Q4: What are the emerging technologies and trends in the opioid use disorder (OUD) treatment market?
Q5: Which region will dominate the opioid use disorder (OUD) treatment market?
Customers who bought this item also bought
Antibiotic Resistance Market: Current Analysis and Forecast (2024-2032)
Emphasis on Disease Type (Urinary Tract Infections, Intra-Abdominal Infections, Blood Stream Infections, Clostridium Difficile Infections, And Others); Pathogen Type (Acinetobacter baumannii, Pseudomonas aeruginosa, Staphylococcus aureus, Streptococcus pneumoniae, and Others); Drug Class (Oxazolidinones, Lipoglycopeptides, Tetracyclines, and Others); and Region/Country
October 8, 2024
